compounded glp-1 risks Medications (e.g. Semaglutide and Tirzepatide): Why South Africans Should Be Cautious Compounding Pharmacies & GLP-1 Medicine:

Liraglutide improves non-alcoholic fatty liver disease in diabetic mice by modulating inflammatory signaling pathways

Pure Peptide Factory supplies this combination as 10mg Tesamorelin and 5mg Ipamorelin per kit, with batch-specific HPLC verification and domestic cold-chain shipping

In January 2025, Novo Nordisk stated that the United States Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease progression, kidney failure (end-stage renal disease), and cardiovascular disease-related death in individuals with type 2 diabetes and chronic kidney disease (CKD)

Clinical Support This is where the platforms diverge most significantly